Literature DB >> 19255434

Immunostimulatory activity of haptenated proteins.

Noah W Palm1, Ruslan Medzhitov.   

Abstract

Antigen recognition alone is insufficient for the activation of adaptive immune responses mediated by conventional lymphocytes. Additional signals that indicate the origin of the antigen are also required. These signals are generally provided by the innate immune system upon recognition of conserved microbial structures by a variety of pattern recognition receptors (PRRs). The Toll-like receptors (TLRs) are the best-characterized family of PRRs and control the activation of adaptive immune responses to a variety of immunizations and infections. However, recent studies have questioned the role of TLRs in the induction of antibody responses and, thus, this issue has become controversial. In contrast to earlier studies supporting a role for TLRs in antibody responses, these studies used haptenated antigens rather than native antigens for immunization, but did not consider the potential effect of antigen haptenation on immunogenicity. Here, we show that commonly used haptenated proteins, unlike native proteins, are inherently immunogenic. This immunogenicity is TLR-independent, but the T and B cell responses induced are primarily hapten-specific, rather than protein-specific. Thus, although haptens have immunostimulatory activity, it is distinct from classical adjuvants, which induce immune responses directed at the admixed antigens. Our results thus highlight an unappreciated and unique immunogenicity of haptenated proteins, and provide an experimental explanation for a seeming discrepancy between published results.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19255434      PMCID: PMC2660743          DOI: 10.1073/pnas.0809403105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Immune recognition. A new receptor for beta-glucans.

Authors:  G D Brown; S Gordon
Journal:  Nature       Date:  2001-09-06       Impact factor: 49.962

2.  Toll-like receptors control activation of adaptive immune responses.

Authors:  M Schnare; G M Barton; A C Holt; K Takeda; S Akira; R Medzhitov
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

3.  Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling.

Authors:  Amanda L Gavin; Kasper Hoebe; Bao Duong; Takayuki Ota; Christopher Martin; Bruce Beutler; David Nemazee
Journal:  Science       Date:  2006-12-22       Impact factor: 47.728

4.  TLR9 signaling in B cells determines class switch recombination to IgG2a.

Authors:  Andrea Jegerlehner; Patrik Maurer; Juliana Bessa; Heather J Hinton; Manfred Kopf; Martin F Bachmann
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

5.  MyD88 is required for the formation of long-term humoral immunity to virus infection.

Authors:  Heath M Guay; Tatyana A Andreyeva; Robert L Garcea; Raymond M Welsh; Eva Szomolanyi-Tsuda
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

Review 6.  Pathogen recognition and innate immunity.

Authors:  Shizuo Akira; Satoshi Uematsu; Osamu Takeuchi
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

7.  TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses.

Authors:  Alex K Heer; Abdijapar Shamshiev; Alena Donda; Satoshi Uematsu; Shizuo Akira; Manfred Kopf; Benjamin J Marsland
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

8.  Innate immune activation and CD4+ T cell priming during respiratory fungal infection.

Authors:  Amariliz Rivera; Grace Ro; Heather L Van Epps; Tyler Simpson; Ingrid Leiner; Derek B Sant'Angelo; Eric G Pamer
Journal:  Immunity       Date:  2006-10-05       Impact factor: 31.745

Review 9.  Modes of action of Freund's adjuvants in experimental models of autoimmune diseases.

Authors:  A Billiau; P Matthys
Journal:  J Leukoc Biol       Date:  2001-12       Impact factor: 4.962

10.  Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.

Authors:  Elizabeth A Leadbetter; Ian R Rifkin; Andreas M Hohlbaum; Britte C Beaudette; Mark J Shlomchik; Ann Marshak-Rothstein
Journal:  Nature       Date:  2002-04-11       Impact factor: 49.962

View more
  32 in total

1.  [Bone marrow hematopoiesis. Evaluation of the myelogram].

Authors:  E B Vladimirskaia
Journal:  Gematol Transfuziol       Date:  1990-08       Impact factor: 0.172

Review 2.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

3.  Interleukin-10 mediated autoregulation of murine B-1 B-cells and its role in Borrelia hermsii infection.

Authors:  Vishal Sindhava; Michael E Woodman; Brian Stevenson; Subbarao Bondada
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

4.  Allergic host defences.

Authors:  Noah W Palm; Rachel K Rosenstein; Ruslan Medzhitov
Journal:  Nature       Date:  2012-04-25       Impact factor: 49.962

5.  Immunogenicity of antibody drug conjugates: bioanalytical methods and monitoring strategy for a novel therapeutic modality.

Authors:  M Benjamin Hock; Karen E Thudium; Montserrat Carrasco-Triguero; Nikolai F Schwabe
Journal:  AAPS J       Date:  2014-11-08       Impact factor: 4.009

Review 6.  Integration of B cell responses through Toll-like receptors and antigen receptors.

Authors:  David J Rawlings; Marc A Schwartz; Shaun W Jackson; Almut Meyer-Bahlburg
Journal:  Nat Rev Immunol       Date:  2012-03-16       Impact factor: 53.106

7.  Topical Application of the Quaternary Ammonium Compound Didecyldimethylammonium Chloride Activates Type 2 Innate Lymphoid Cells and Initiates a Mixed-Type Allergic Response.

Authors:  Hillary L Shane; Ewa Lukomska; Michael L Kashon; Stacey E Anderson
Journal:  Toxicol Sci       Date:  2019-04-01       Impact factor: 4.849

Review 8.  The role of lipopeptidophosphoglycan in the immune response to Entamoeba histolytica.

Authors:  Isabel Wong-Baeza; Marcela Alcántara-Hernández; Ismael Mancilla-Herrera; Itzmel Ramírez-Saldívar; Lourdes Arriaga-Pizano; Eduardo Ferat-Osorio; Constantino López-Macías; Armando Isibasi
Journal:  J Biomed Biotechnol       Date:  2010-01-21

9.  Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG.

Authors:  Jasper G van den Boorn; Debby Konijnenberg; Esther P M Tjin; Daisy I Picavet; Nico J Meeuwenoord; Dmitri V Filippov; J P Wietze van der Veen; Jan D Bos; Cornelis J M Melief; Rosalie M Luiten
Journal:  PLoS One       Date:  2010-05-13       Impact factor: 3.240

Review 10.  Inflammatory mediators in mastitis and lactation insufficiency.

Authors:  Wendy V Ingman; Danielle J Glynn; Mark R Hutchinson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-06-25       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.